Fig. 1 · Structure

Documents & Downloads

Nimorazole

Cat. No. A13091 CAS 6506-37-2
Nimorazole is a nitroimidazole anti-infective. It is also being investigated for the treatment of head and neck cancer.

In Stock

Publications for Nimorazole

2 publications citing this product

  1. Eero Itala, .et al. , J. Phys. Chem. A, 2020, 124, 27, 5555-5562 PMID: 32513004
  2. Elodie Melsens, .et al. , Radiat Oncol, 2018, 13: 39 PMID: 29514673

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
HCT-116 IC50 9.8 mM Cytotoxicity against human HCT116 cells incubated for 4 hrs under anaerobic condition measured after 5 days by sulforhodamine B assay [PMID: 29253343]

Specifications

Manufacturer Adooq Bioscience
CAS Number 6506-37-2
Formula C9H14N4O3
Molecular Weight 226.23
SMILES
C1COCCN1CCN2C=NC=C2[N+](=O)[O-]

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 41 mg/mL (181.23 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Publications

2 publications citing this product

  1. Eero Itala, .et al. , J. Phys. Chem. A, 2020, 124, 27, 5555-5562 PMID: 32513004
  2. Elodie Melsens, .et al. , Radiat Oncol, 2018, 13: 39 PMID: 29514673

Added to your cart

View Cart Checkout
Loading...